Is this you? Create Your Porfile
Avatar

Elmar Kraus

ImmunoGen, Inc.

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Elmar Kraus is active.

Explore More

Publication

Featured researches published by Elmar Kraus.

Archive | 2010

Agent for treating disease

Matthias Germer; Frank Osterroth; Silke Aigner; Christoph Uherek; Elmar Kraus; Andrea Wartenberg-Demand; Daniele Wolf; Sibylle Kaiser; Juergen Lindner; Christoph Bruecher; Benjamin Daelken

Archive | 2008

Agents targeting CD138 and uses thereof

Elmar Kraus; Christoph Bruecher; Benjamin Daelken; Matthias Germer; Steffen Zeng; Frank Osterroth; Christoph Uherek; Silke Aigner; Gregor Schulz

Archive | 2008

Immunoconjugates targeting cd138 and uses thereof

Elmar Kraus; Christoph Bruecher; Benjamin Daelken; Steffen Zeng; Frank Osterroth; Christoph Uherek; Silke Aigner; Matthias Germer

Archive | 2008

Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugates

Gregor Schulz; Christoph Bruecher; Frank Osterroth; Steffen Zeng; Christoph Uherek; Silke Aigner; Benjamin Daelken; Markus Ruehle; Elmar Kraus

Archive | 2009

DOSING REGIMEN FOR TREATING PSORIASIS AND RHEUMATOID ARTHRITIS

Frank Osterroth; Silke Aigner; Matthias Germer; Christoph Uherek; Elmar Kraus; Andrea Wartenberg-Demand; Daniele Wolf; Sibylle Kaiser; Juergen Lindner; Christoph Bruecher; Benjamin Daelken; Gregor Schulz

Archive | 2009

Anti-CD4 antibody dosage regimen for treating autoimmune disease

Silke Aigner; Matthias Germer; Frank Osterroth; Christoph Uherek; Elmar Kraus; Andrea Wartenberg-Demand; Daniele Wolf; Sibylle Kaiser; Juergen Lindner; Christoph Bruecher; Benjamin Daelken; Gregor Schulz

Archive | 2008

Wirkstoffe für CD138-Targeting und Verwendungen davon

Elmar Kraus; Christoph Bruecher; Benjamin Daelken; Matthias Germer; Steffen Zeng; Frank Osterroth; Christoph Uherek; Silke Aigner; Gregor Schulz

Archive | 2008

Immunoconjugués ciblant cd138 et utilisations de ceux-ci

Elmar Kraus; Christoph Bruecher; Benjamin Daelken; Steffen Zeng; Frank Osterroth; Christoph Uherek; Silke Aigner; Matthias Germer

Archive | 2008

Verfahren zur verminderung der zytotoxischen nebenwirkungen und zur erhöhung der wirksamkeit von immunkonjugaten

Silke Aigner; Christoph Bruecher; Benjamin Daelken; Elmar Kraus; Frank Osterroth; Markus Ruehle; Gregor Schulz; Christoph Uherek; Steffen Zeng

Archive | 2008

Auf cd138 zielende immunkonjugate und anwendungen davon

Elmar Kraus; Christoph Bruecher; Benjamin Daelken; Steffen Zeng; Frank Osterroth; Christoph Uherek; Silke Aigner; Matthias Germer

Explore More

Collaboration

Dive into the Elmar Kraus's collaboration.

Top Co-Authors
Avatar

Benjamin Daelken

ImmunoGen

View shared research outputs
Top Co-Authors
Avatar

Christoph Bruecher

ImmunoGen

View shared research outputs
Top Co-Authors
Avatar

Frank Osterroth

Harvard University

View shared research outputs
Top Co-Authors
Avatar

Silke Aigner

Harvard University

View shared research outputs
Top Co-Authors
Avatar

Matthias Germer

ImmunoGen

View shared research outputs
Top Co-Authors
Avatar

Christoph Uherek

Goethe University Frankfurt

View shared research outputs
Top Co-Authors
Avatar

Steffen Zeng

ImmunoGen

View shared research outputs
Top Co-Authors
Avatar

Gregor Schulz

ImmunoGen

View shared research outputs
Top Co-Authors
Avatar

Andrea Wartenberg-Demand

ImmunoGen

View shared research outputs
Top Co-Authors
Avatar

Christoph Uherek

Goethe University Frankfurt

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge